BeStock  

Ironwood Pharmaceuticals IRWD

US equityMarket cap rank #3604Drug Manufacturers - Specialty & Generic
$3.75 +$0.12 (+3.31%)
Pre-market · Oct 8, 9:00 am ET · After hours $3.54 -5.59%
Open$3.58
Prev close$3.63
Day range$3.54 – $3.87
Volume2.05M
Market cap$619.65M
P/E (TTM)4.7
Dividend yield–

Earnings

Average move on report day±7.4%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+3.6%
Worst reaction-32.6%

Stock move on the day after each report

+1.3%2022/Q4+0.7%2023/Q1-9.2%2023/Q2+3.1%2023/Q3-3.0%2023/Q4-17.0%2024/Q1-32.6%2024/Q2-7.5%2024/Q3-5.3%2024/Q4-11.3%2025/Q4-13.7%2026/Q1+2.7%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q26 Aug 2026Pre Market±14.7%+2.65%Within range
2026/Q17 May 2026Pre Market±13.5%-13.66%Bigger than priced
2025/Q425 Feb 2026Pre Market±20.6%-11.35%Within range
2024/Q427 Feb 2025Pre Market–-5.26%–
2024/Q37 Nov 2024Pre Market±17.2%-7.54%Within range
2024/Q28 Aug 2024Pre Market±33.8%-32.61%Within range
2024/Q19 May 2024Pre Market±19.5%-17.00%Within range
2023/Q415 Feb 2024Pre Market±12.9%-2.98%Within range
2023/Q39 Nov 2023Pre Market±14.8%+3.14%Within range
2023/Q28 Aug 2023Pre Market±16.6%-9.16%Within range
2023/Q14 May 2023Pre Market±6.7%+0.67%Within range
2022/Q416 Feb 2023Pre Market±17.4%+1.34%Within range
2022/Q33 Nov 2022Pre Market±9.9%+3.65%Within range
2022/Q24 Aug 2022Pre Market±27.3%+2.41%Within range
2022/Q15 May 2022Pre Market±14.8%-1.29%Within range
2021/Q417 Feb 2022Pre Market±11.8%-3.55%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$113.04M+32.6% YoY
Operating profit$79.31M+76.0% YoY
Net profit$51.29M+117.3% YoY
Diluted EPS$0.31+121.4% YoY
Free cash flow$58.28M+486.7% YoY
Operating cash flow$58.28M

Revenue, last 8 quarters

$91.6MSep '24$90.5MDec '24$41.1MMar '25$85.2MJun '25$122.1MSep '25$47.7MDec '25$106.5MMar '26$113.0MJun '26

Net profit, last 8 quarters

$3.6MSep '24$2.3MDec '24$-37.4MMar '25$23.6MJun '25$40.1MSep '25$-2.3MDec '25$40.8MMar '26$51.3MJun '26

Profitability & balance sheet

Operating margin60.6%
Net margin33.4%
Return on assets41.4%
Current ratio6.06
Liabilities / assets156.8%
Cash & investments$79.13M
Total debt$393.58M
Net cash (debt)-$314.45M
Free cash flow / sales47.7%

Discussion

No comments yet — be the first to weigh in on IRWD.

Leave a comment

Scroll to Top